Ultra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry)

[1]  J. Tremmel,et al.  Can we bear another bare‐metal stent study? , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  G. Richardt,et al.  Safety and efficacy of the cobalt chromium PRO-Kinetik coronary stent system: results of the MULTIBENE study. , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[3]  G. Lip,et al.  The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries. , 2012, Journal of interventional cardiology.

[4]  G. Biondi‐Zoccai,et al.  Synergy Between Direct Coronary Stenting Technique and Use of the Novel Thin Strut Cobalt Chromium Skylor™ Stent: the Mace in Follow Up Patients Treated with Skylor Stent [MILES Study] , 2012, Current cardiology reviews.

[5]  G. Dangas,et al.  Early Stent Thrombosis after Percutaneous Coronary Intervention for Acute Myocardial Infarction , 2011 .

[6]  P. Serruys,et al.  Delineating the Numerous Causes of Drug-Eluting Stent Restenosis , 2011 .

[7]  K. Robinson,et al.  A third generation ultra-thin strut cobalt chromium stent: histopathological evaluation in porcine coronary arteries. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[8]  A. Rebuzzi,et al.  Thin strut chrome–cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform , 2009, Journal of cardiovascular medicine.

[9]  Omar Ismail,et al.  Clinical safety and efficacy of a novel thin‐strut cobalt–chromium coronary stent system: Results of the real world Coroflex Blue Registry , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  H. Gwon,et al.  Multi-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: a prospective, multi-center study. , 2007, Chinese medical journal.

[11]  M. Gyöngyösi,et al.  Small vessel stenting with cobalt–chromium stents (Arthos Pico) in a real world setting , 2007, Coronary artery disease.

[12]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[13]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[14]  Patrick Hunziker,et al.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. , 2006, Journal of the American College of Cardiology.

[15]  K. Hauptmann,et al.  Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in stable and unstable angina pectoris. , 2006, The American journal of cardiology.

[16]  P. Buser,et al.  Incremental Cost-Effectiveness of Drug-Eluting Stents Compared With a Third-Generation Bare-Metal Stent in a Real-World Setting: Randomised Basel Stent Kosten Effektivitats Trial (BASKET) , 2005 .

[17]  Christoph Kaiser,et al.  Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET) , 2005, The Lancet.

[18]  A. Kastrati,et al.  Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. , 2005, European heart journal.

[19]  John F LaDisa,et al.  Circumferential vascular deformation after stent implantation alters wall shear stress evaluated with time-dependent 3D computational fluid dynamics models. , 2005, Journal of applied physiology.

[20]  M. Leon,et al.  Usefulness of a cobalt chromium coronary stent alloy. , 2003, The American journal of cardiology.

[21]  P. Berger.  Can euphoria be bad? , 2003, Journal of the American College of Cardiology.

[22]  A. Kastrati,et al.  [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial]. , 2012, Vestnik rentgenologii i radiologii.

[23]  A. Kastrati,et al.  Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.

[24]  A. Kastrati,et al.  Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. , 2003, Journal of the American College of Cardiology.

[25]  J. Ormiston,et al.  Stent longitudinal flexibility: A comparison of 13 stent designs before and after balloon expansion , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[26]  M. S. Williams,et al.  Stent and artery geometry determine intimal thickening independent of arterial injury. , 2000, Circulation.

[27]  T. Ryan.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.

[28]  B. Rutherford,et al.  Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. , 2005, The American journal of cardiology.

[29]  J. Palmaz,et al.  Influence of topography on endothelialization of stents: clues for new designs. , 2000, Journal of long-term effects of medical implants.

[30]  J. Palmaz,et al.  Protein interactions with endovascular prosthetic surfaces. , 2000, Journal of long-term effects of medical implants.